서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 40 of 52

Issue DateTitle / Author(s) / CitationFileAltmetrics
2007-08
Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naive adults
DOI
2012-03
Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients
DOI
2013-01
RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: An evaluator-blind, randomized, pilot study

Lee, D. H.; Kang, S. M.; Feneran, A.; Youn, C. S.; Kim, J. K.; Cho, S.; Won, C. H.; Chang, S. E.; Lee, M. W.; Choi, J. H.; Moon, K. C.

Journal of the European Academy of Dermatology and Venereology, Vol.27 No.1, pp.e1-e7

DOI
2014-08
Development of antirituximab antibodies in children with nephrotic syndrome

Ahn, Yo Han; Kang, Hee Gyung; Lee, Jiwon M.; Choi, Hyun Jin; Ha, Il-Soo; Cheong, Hae Il

Pediatric Nephrology, Vol.29 No.8, pp.1461-1464

DOI
2014-11
Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
DOI
2015-07
Intravitreally injected anti-VEGF antibody reduces brown fat in neonatal mice
DOI
2016-03
Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study
DOI
2016-06
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
DOI
2016-07
Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer
DOI
2016-10
Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit

Han, Ji-Min; Ah, Young-Mi; Suh, Sung Yun; Jung, Sun-Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun

International Journal of Clinical Pharmacy, Vol.38 No.5, pp.1124-1132

DOI
2016-12
Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer
DOI
2017-05
CONSECUTIVE ANALYSIS OF MUTATION SPECTRUM IN THE DYSTROPHIN GENE OF 507 KOREAN BOYS WITH DUCHENNE/BECKER MUSCULAR DYSTROPHY IN A SINGLE CENTER
DOI
2017-06
Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
DOI
2017-08
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
DOI
2017-09
Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy
DOI
2017-11
PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
DOI
2018-02
Phase I pharmacokinetic study of nivolumab in Korean patients with advanced solid tumors
DOI
2018-02
Early therapeutic drug monitoring of posaconazole oral suspension in patients with hematologic malignancies
DOI
2018-03
Phase III, Randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor-positive metastatic breast cancer: ALTERNATIVE
DOI
2018-03
Long-term trastuzumab (Herceptin (R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
view fileDOI
2018-03
Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012
DOI
2018-08
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
DOI
2018-08
Low-dose nivolumab can be effective in non-small cell lung cancer: Alternative option for financial toxicity
DOI
2018-11
Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis

Jeong, Seon Hwa; Lee, Dayong; Kim, Seul Ki; Jee, Byung Chul

Gynecological Endocrinology, Vol.34 No.11, pp.970-974

DOI
2019-01
Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus
DOI
2019-02
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
DOI
2019-05
Palbociclib plus letrozole as first-line therapy in postmenopausal Asian women with metastatic breast cancer: Results from the phase III, randomized PALOMA-2 study
DOI
2019-06
Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea
view fileDOI
2019-07
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
DOI
2019-07
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent-3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial -
DOI
2019-08
Immunogenicity of the varicella-zoster vaccine in community-dwelling non-robust elderly individuals compared to robust elderly individuals: A prospective cohort study

Choi, Jung-Yeon; Kang, Min-gu; Park, Kyoung Un; Park, Wan Beom; Kim, Kwang-il; Kim, Eu Suk; Kim, Hong Bin; Song, Kyoung-Ho; Kim, Cheol-Ho

Journals of Gerontology - Series Ahttps://s-rims.snu.ac.kr/auth/article/articlePopup.do# Biological Sciences and Medical Sciences, Vol.74 No.8, pp.1225-1230

DOI
2019-09
Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis

Choi, Kyomin; Hong, Yoon-Ho; Ahn, So-Hyun; Baek, Seot-Hee; Kim, Jun-Soon; Shin, Je-Young; Sung, Jung-Joon

Therapeutic Advances in Neurological Disorders, Vol.12

DOI
2019-10
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC
DOI
2019-10
Programmed cell death ligand-1 (PD-L1) expression in extrahepatic biliary tract cancers: a comparative study using 22C3, SP263 and E1L3N anti-PD-L1 antibodies
DOI
2019-11
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer
DOI
2019-12
Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer
DOI
2020-03
The effects of letrozole on women with endometriosis undergoing ovarian stimulation for in vitro fertilization
DOI
2020-04
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
DOI
2020-04
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
DOI
2020-06
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): A randomised, open-label, phase 2 trial
DOI
1 2